nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—UGT2B7—Epirubicin—sarcoma	0.0579	0.0854	CbGbCtD
Diclofenac—ABCC1—Dactinomycin—sarcoma	0.0568	0.0838	CbGbCtD
Diclofenac—CYP2B6—Thiotepa—sarcoma	0.0556	0.0821	CbGbCtD
Diclofenac—ABCC1—Mitoxantrone—sarcoma	0.0508	0.075	CbGbCtD
Diclofenac—ABCC1—Epirubicin—sarcoma	0.0411	0.0607	CbGbCtD
Diclofenac—CYP1A1—Dacarbazine—sarcoma	0.0404	0.0597	CbGbCtD
Diclofenac—UGT1A1—Etoposide—sarcoma	0.039	0.0575	CbGbCtD
Diclofenac—ABCC1—Vincristine—sarcoma	0.035	0.0516	CbGbCtD
Diclofenac—ABCC1—Etoposide—sarcoma	0.032	0.0473	CbGbCtD
Diclofenac—CYP2E1—Dacarbazine—sarcoma	0.0312	0.0461	CbGbCtD
Diclofenac—CYP2E1—Mitoxantrone—sarcoma	0.0242	0.0358	CbGbCtD
Diclofenac—PTGS2—Etoposide—sarcoma	0.0234	0.0346	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—sarcoma	0.0218	0.0322	CbGbCtD
Diclofenac—PTGS1—Etoposide—sarcoma	0.0198	0.0292	CbGbCtD
Diclofenac—CYP1A2—Dacarbazine—sarcoma	0.0181	0.0267	CbGbCtD
Diclofenac—CYP3A4—Thiotepa—sarcoma	0.0171	0.0252	CbGbCtD
Diclofenac—CYP2E1—Etoposide—sarcoma	0.0153	0.0226	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—sarcoma	0.0137	0.0202	CbGbCtD
Diclofenac—ABCB1—Mitoxantrone—sarcoma	0.0123	0.0181	CbGbCtD
Diclofenac—CYP2C8—Etoposide—sarcoma	0.0114	0.0169	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—sarcoma	0.0103	0.0152	CbGbCtD
Diclofenac—CYP1A2—Etoposide—sarcoma	0.00884	0.013	CbGbCtD
Diclofenac—ABCB1—Vincristine—sarcoma	0.00843	0.0125	CbGbCtD
Diclofenac—ABCB1—Etoposide—sarcoma	0.00773	0.0114	CbGbCtD
Diclofenac—CYP3A4—Mitoxantrone—sarcoma	0.00734	0.0108	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—sarcoma	0.00527	0.00778	CbGbCtD
Diclofenac—CYP3A4—Vincristine—sarcoma	0.00505	0.00746	CbGbCtD
Diclofenac—CYP3A4—Etoposide—sarcoma	0.00463	0.00684	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—sarcoma	0.00316	0.00466	CbGbCtD
Diclofenac—CXCR1—bone marrow—sarcoma	0.00193	0.0313	CbGeAlD
Diclofenac—PTGS2—periosteum—sarcoma	0.00157	0.0254	CbGeAlD
Diclofenac—PLA2G2A—myometrium—sarcoma	0.00126	0.0204	CbGeAlD
Diclofenac—PTGS2—leg—sarcoma	0.00125	0.0202	CbGeAlD
Diclofenac—CXCL8—myometrium—sarcoma	0.00125	0.0202	CbGeAlD
Diclofenac—CXCR1—lymph node—sarcoma	0.0012	0.0194	CbGeAlD
Diclofenac—PLA2G2A—seminal vesicle—sarcoma	0.00114	0.0184	CbGeAlD
Diclofenac—PTGS2—hindlimb—sarcoma	0.00112	0.0181	CbGeAlD
Diclofenac—PTGS2—cartilage tissue—sarcoma	0.0011	0.0178	CbGeAlD
Diclofenac—PLA2G2A—hematopoietic system—sarcoma	0.00108	0.0175	CbGeAlD
Diclofenac—PLA2G2A—connective tissue—sarcoma	0.00104	0.0168	CbGeAlD
Diclofenac—ASIC1—testis—sarcoma	0.000983	0.0159	CbGeAlD
Diclofenac—PTGS2—appendage—sarcoma	0.000957	0.0155	CbGeAlD
Diclofenac—PLA2G2A—smooth muscle tissue—sarcoma	0.000952	0.0154	CbGeAlD
Diclofenac—CXCL8—smooth muscle tissue—sarcoma	0.000942	0.0153	CbGeAlD
Diclofenac—TTR—embryo—sarcoma	0.000914	0.0148	CbGeAlD
Diclofenac—ALB—mammary gland—sarcoma	0.000855	0.0138	CbGeAlD
Diclofenac—PLA2G2A—cardiac atrium—sarcoma	0.000821	0.0133	CbGeAlD
Diclofenac—TTR—hematopoietic system—sarcoma	0.000816	0.0132	CbGeAlD
Diclofenac—TTR—connective tissue—sarcoma	0.000786	0.0127	CbGeAlD
Diclofenac—UGT1A1—hematopoietic system—sarcoma	0.000773	0.0125	CbGeAlD
Diclofenac—PLA2G2A—lymphoid tissue—sarcoma	0.000761	0.0123	CbGeAlD
Diclofenac—ALOX5—hematopoietic system—sarcoma	0.000739	0.012	CbGeAlD
Diclofenac—KCNQ2—testis—sarcoma	0.000719	0.0116	CbGeAlD
Diclofenac—PLA2G2A—tendon—sarcoma	0.000715	0.0116	CbGeAlD
Diclofenac—ASIC1—lymph node—sarcoma	0.000712	0.0115	CbGeAlD
Diclofenac—ALOX5—connective tissue—sarcoma	0.000712	0.0115	CbGeAlD
Diclofenac—CXCL8—bone marrow—sarcoma	0.000686	0.0111	CbGeAlD
Diclofenac—ALOX5—smooth muscle tissue—sarcoma	0.000651	0.0105	CbGeAlD
Diclofenac—PTGS1—endothelium—sarcoma	0.000604	0.00978	CbGeAlD
Diclofenac—CYP2C8—mammary gland—sarcoma	0.000601	0.00972	CbGeAlD
Diclofenac—PLA2G2A—testis—sarcoma	0.000592	0.00959	CbGeAlD
Diclofenac—CXCL8—testis—sarcoma	0.000586	0.00949	CbGeAlD
Diclofenac—PTGS2—endothelium—sarcoma	0.000578	0.00935	CbGeAlD
Diclofenac—TTR—lymphoid tissue—sarcoma	0.000574	0.0093	CbGeAlD
Diclofenac—PLA2G2A—liver—sarcoma	0.00056	0.00906	CbGeAlD
Diclofenac—SCN4A—tendon—sarcoma	0.000555	0.00898	CbGeAlD
Diclofenac—CXCL8—liver—sarcoma	0.000554	0.00897	CbGeAlD
Diclofenac—CYP2C9—mammary gland—sarcoma	0.000534	0.00864	CbGeAlD
Diclofenac—TTR—bone marrow—sarcoma	0.000523	0.00847	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—sarcoma	0.000521	0.00842	CbGeAlD
Diclofenac—CYP2C18—liver—sarcoma	0.000511	0.00827	CbGeAlD
Diclofenac—ABCC4—hematopoietic system—sarcoma	0.000504	0.00816	CbGeAlD
Diclofenac—ABCC1—myometrium—sarcoma	0.000501	0.0081	CbGeAlD
Diclofenac—SLCO1C1—testis—sarcoma	0.0005	0.0081	CbGeAlD
Diclofenac—SLC22A8—hematopoietic system—sarcoma	0.0005	0.00809	CbGeAlD
Diclofenac—UGT2B7—testis—sarcoma	0.000499	0.00807	CbGeAlD
Diclofenac—ALOX5—bone marrow—sarcoma	0.000474	0.00767	CbGeAlD
Diclofenac—UGT2B7—liver—sarcoma	0.000471	0.00763	CbGeAlD
Diclofenac—SCN4A—testis—sarcoma	0.00046	0.00744	CbGeAlD
Diclofenac—SLC22A11—liver—sarcoma	0.000459	0.00743	CbGeAlD
Diclofenac—ABCC1—seminal vesicle—sarcoma	0.000452	0.00732	CbGeAlD
Diclofenac—TTR—testis—sarcoma	0.000447	0.00724	CbGeAlD
Diclofenac—PLA2G2A—lymph node—sarcoma	0.000429	0.00695	CbGeAlD
Diclofenac—CXCL8—lymph node—sarcoma	0.000425	0.00688	CbGeAlD
Diclofenac—TTR—liver—sarcoma	0.000423	0.00684	CbGeAlD
Diclofenac—CYP2C19—hematopoietic system—sarcoma	0.000419	0.00679	CbGeAlD
Diclofenac—ALOX5—testis—sarcoma	0.000405	0.00656	CbGeAlD
Diclofenac—UGT1A1—liver—sarcoma	0.000401	0.00649	CbGeAlD
Diclofenac—ALOX5—liver—sarcoma	0.000383	0.0062	CbGeAlD
Diclofenac—ABCC4—uterus—sarcoma	0.000381	0.00616	CbGeAlD
Diclofenac—CYP2C8—hematopoietic system—sarcoma	0.000366	0.00592	CbGeAlD
Diclofenac—SLCO1C1—lymph node—sarcoma	0.000363	0.00587	CbGeAlD
Diclofenac—CYP1A2—hematopoietic system—sarcoma	0.000342	0.00554	CbGeAlD
Diclofenac—CYP1A1—hematopoietic system—sarcoma	0.000338	0.00547	CbGeAlD
Diclofenac—ABCC4—tendon—sarcoma	0.000334	0.0054	CbGeAlD
Diclofenac—PTGS2—myometrium—sarcoma	0.00033	0.00535	CbGeAlD
Diclofenac—CYP2B6—hematopoietic system—sarcoma	0.000328	0.00531	CbGeAlD
Diclofenac—ABCC1—cardiac atrium—sarcoma	0.000326	0.00528	CbGeAlD
Diclofenac—CYP2C9—hematopoietic system—sarcoma	0.000325	0.00526	CbGeAlD
Diclofenac—ABCC1—uterus—sarcoma	0.000325	0.00525	CbGeAlD
Diclofenac—CYP2E1—seminal vesicle—sarcoma	0.000324	0.00525	CbGeAlD
Diclofenac—ABCC4—bone marrow—sarcoma	0.000323	0.00523	CbGeAlD
Diclofenac—PTGS2—embryo—sarcoma	0.000318	0.00514	CbGeAlD
Diclofenac—PTGS1—seminal vesicle—sarcoma	0.000312	0.00505	CbGeAlD
Diclofenac—CYP2E1—hematopoietic system—sarcoma	0.000308	0.00499	CbGeAlD
Diclofenac—PTGS2—seminal vesicle—sarcoma	0.000298	0.00483	CbGeAlD
Diclofenac—PTGS1—hematopoietic system—sarcoma	0.000297	0.0048	CbGeAlD
Diclofenac—CYP1A1—skin of body—sarcoma	0.000294	0.00475	CbGeAlD
Diclofenac—ALOX5—lymph node—sarcoma	0.000294	0.00475	CbGeAlD
Diclofenac—PTGS1—connective tissue—sarcoma	0.000286	0.00462	CbGeAlD
Diclofenac—CYP2B6—skin of body—sarcoma	0.000285	0.00462	CbGeAlD
Diclofenac—ALB—testis—sarcoma	0.000285	0.00462	CbGeAlD
Diclofenac—ABCC1—tendon—sarcoma	0.000284	0.0046	CbGeAlD
Diclofenac—PTGS2—hematopoietic system—sarcoma	0.000284	0.00459	CbGeAlD
Diclofenac—ABCC4—testis—sarcoma	0.000276	0.00447	CbGeAlD
Diclofenac—PTGS2—connective tissue—sarcoma	0.000273	0.00442	CbGeAlD
Diclofenac—ALB—liver—sarcoma	0.00027	0.00437	CbGeAlD
Diclofenac—PTGS1—smooth muscle tissue—sarcoma	0.000261	0.00423	CbGeAlD
Diclofenac—ABCC4—liver—sarcoma	0.000261	0.00423	CbGeAlD
Diclofenac—PTGS1—skin of body—sarcoma	0.000258	0.00418	CbGeAlD
Diclofenac—CYP1A1—cardiac atrium—sarcoma	0.000257	0.00415	CbGeAlD
Diclofenac—CYP1A1—uterus—sarcoma	0.000255	0.00413	CbGeAlD
Diclofenac—PTGS2—smooth muscle tissue—sarcoma	0.00025	0.00404	CbGeAlD
Diclofenac—CYP3A4—hematopoietic system—sarcoma	0.000248	0.00401	CbGeAlD
Diclofenac—PTGS2—skin of body—sarcoma	0.000247	0.00399	CbGeAlD
Diclofenac—ABCC1—testis—sarcoma	0.000236	0.00381	CbGeAlD
Diclofenac—CYP2B6—lymphoid tissue—sarcoma	0.000231	0.00374	CbGeAlD
Diclofenac—PTGS1—cardiac atrium—sarcoma	0.000225	0.00365	CbGeAlD
Diclofenac—PTGS1—uterus—sarcoma	0.000224	0.00363	CbGeAlD
Diclofenac—ABCC1—liver—sarcoma	0.000223	0.0036	CbGeAlD
Diclofenac—CYP2C19—liver—sarcoma	0.000217	0.00352	CbGeAlD
Diclofenac—CYP2E1—lymphoid tissue—sarcoma	0.000217	0.00351	CbGeAlD
Diclofenac—PTGS2—uterus—sarcoma	0.000214	0.00347	CbGeAlD
Diclofenac—ALB—lymph node—sarcoma	0.000207	0.00335	CbGeAlD
Diclofenac—ABCB1—myometrium—sarcoma	0.000204	0.00331	CbGeAlD
Diclofenac—CYP2E1—tendon—sarcoma	0.000204	0.0033	CbGeAlD
Diclofenac—CYP2C8—testis—sarcoma	0.000201	0.00325	CbGeAlD
Diclofenac—ABCC4—lymph node—sarcoma	0.0002	0.00324	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—sarcoma	0.0002	0.00323	CbGeAlD
Diclofenac—ABCB1—embryo—sarcoma	0.000197	0.00318	CbGeAlD
Diclofenac—PTGS1—tendon—sarcoma	0.000196	0.00318	CbGeAlD
Diclofenac—CYP2C8—liver—sarcoma	0.00019	0.00307	CbGeAlD
Diclofenac—PTGS2—tendon—sarcoma	0.000188	0.00304	CbGeAlD
Diclofenac—ABCB1—seminal vesicle—sarcoma	0.000185	0.00299	CbGeAlD
Diclofenac—PTGS2—bone marrow—sarcoma	0.000182	0.00294	CbGeAlD
Diclofenac—CYP2B6—testis—sarcoma	0.00018	0.00291	CbGeAlD
Diclofenac—CYP1A2—liver—sarcoma	0.000177	0.00287	CbGeAlD
Diclofenac—ABCB1—hematopoietic system—sarcoma	0.000175	0.00284	CbGeAlD
Diclofenac—CYP1A1—liver—sarcoma	0.000175	0.00283	CbGeAlD
Diclofenac—ABCC1—lymph node—sarcoma	0.000171	0.00276	CbGeAlD
Diclofenac—CYP2B6—liver—sarcoma	0.00017	0.00275	CbGeAlD
Diclofenac—CYP2E1—testis—sarcoma	0.000169	0.00273	CbGeAlD
Diclofenac—CYP2C9—liver—sarcoma	0.000168	0.00273	CbGeAlD
Diclofenac—PTGS1—testis—sarcoma	0.000163	0.00263	CbGeAlD
Diclofenac—CYP2E1—liver—sarcoma	0.00016	0.00258	CbGeAlD
Diclofenac—PTGS2—liver—sarcoma	0.000147	0.00238	CbGeAlD
Diclofenac—CYP1A1—lymph node—sarcoma	0.000134	0.00217	CbGeAlD
Diclofenac—ABCB1—uterus—sarcoma	0.000133	0.00215	CbGeAlD
Diclofenac—CYP3A4—liver—sarcoma	0.000128	0.00208	CbGeAlD
Diclofenac—ABCB1—lymphoid tissue—sarcoma	0.000124	0.002	CbGeAlD
Diclofenac—PTGS1—lymph node—sarcoma	0.000118	0.00191	CbGeAlD
Diclofenac—PTGS2—lymph node—sarcoma	0.000113	0.00182	CbGeAlD
Diclofenac—ABCB1—bone marrow—sarcoma	0.000112	0.00182	CbGeAlD
Diclofenac—Pancytopenia—Doxorubicin—sarcoma	0.000103	0.000506	CcSEcCtD
Diclofenac—Renal failure—Epirubicin—sarcoma	0.000102	0.000504	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Etoposide—sarcoma	0.000102	0.000504	CcSEcCtD
Diclofenac—Asthenia—Mitoxantrone—sarcoma	0.000102	0.000504	CcSEcCtD
Diclofenac—Fatigue—Etoposide—sarcoma	0.000102	0.000503	CcSEcCtD
Diclofenac—Neuropathy peripheral—Epirubicin—sarcoma	0.000102	0.000503	CcSEcCtD
Diclofenac—Stomatitis—Epirubicin—sarcoma	0.000102	0.0005	CcSEcCtD
Diclofenac—Jaundice—Epirubicin—sarcoma	0.000102	0.0005	CcSEcCtD
Diclofenac—Constipation—Etoposide—sarcoma	0.000101	0.000499	CcSEcCtD
Diclofenac—Pain—Etoposide—sarcoma	0.000101	0.000499	CcSEcCtD
Diclofenac—Urinary tract infection—Epirubicin—sarcoma	0.000101	0.000499	CcSEcCtD
Diclofenac—Conjunctivitis—Epirubicin—sarcoma	0.000101	0.000499	CcSEcCtD
Diclofenac—Dysuria—Doxorubicin—sarcoma	0.000101	0.000498	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000101	0.000495	CcSEcCtD
Diclofenac—Diarrhoea—Vincristine—sarcoma	0.0001	0.000493	CcSEcCtD
Diclofenac—Sweating—Epirubicin—sarcoma	9.99e-05	0.000492	CcSEcCtD
Diclofenac—Pollakiuria—Doxorubicin—sarcoma	9.99e-05	0.000492	CcSEcCtD
Diclofenac—Haematuria—Epirubicin—sarcoma	9.94e-05	0.000489	CcSEcCtD
Diclofenac—Photosensitivity reaction—Doxorubicin—sarcoma	9.87e-05	0.000486	CcSEcCtD
Diclofenac—Hepatobiliary disease—Epirubicin—sarcoma	9.86e-05	0.000485	CcSEcCtD
Diclofenac—Weight increased—Doxorubicin—sarcoma	9.85e-05	0.000485	CcSEcCtD
Diclofenac—Epistaxis—Epirubicin—sarcoma	9.83e-05	0.000484	CcSEcCtD
Diclofenac—Nausea—Thiotepa—sarcoma	9.81e-05	0.000483	CcSEcCtD
Diclofenac—Weight decreased—Doxorubicin—sarcoma	9.79e-05	0.000482	CcSEcCtD
Diclofenac—Sinusitis—Epirubicin—sarcoma	9.78e-05	0.000481	CcSEcCtD
Diclofenac—Feeling abnormal—Etoposide—sarcoma	9.77e-05	0.000481	CcSEcCtD
Diclofenac—Hyperglycaemia—Doxorubicin—sarcoma	9.76e-05	0.00048	CcSEcCtD
Diclofenac—Diarrhoea—Mitoxantrone—sarcoma	9.76e-05	0.00048	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—sarcoma	9.73e-05	0.000479	CcSEcCtD
Diclofenac—Agranulocytosis—Epirubicin—sarcoma	9.73e-05	0.000479	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—sarcoma	9.7e-05	0.000478	CcSEcCtD
Diclofenac—Gastrointestinal pain—Etoposide—sarcoma	9.7e-05	0.000477	CcSEcCtD
Diclofenac—Dizziness—Vincristine—sarcoma	9.68e-05	0.000477	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—sarcoma	9.65e-05	0.000475	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—sarcoma	9.65e-05	0.000475	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—sarcoma	9.65e-05	0.000475	CcSEcCtD
Diclofenac—ABCB1—testis—sarcoma	9.62e-05	0.00156	CbGeAlD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—sarcoma	9.56e-05	0.000471	CcSEcCtD
Diclofenac—Bradycardia—Epirubicin—sarcoma	9.53e-05	0.000469	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—sarcoma	9.48e-05	0.000467	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—sarcoma	9.45e-05	0.000465	CcSEcCtD
Diclofenac—Urticaria—Etoposide—sarcoma	9.42e-05	0.000464	CcSEcCtD
Diclofenac—Haemoglobin—Epirubicin—sarcoma	9.41e-05	0.000463	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—sarcoma	9.4e-05	0.000463	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—sarcoma	9.4e-05	0.000463	CcSEcCtD
Diclofenac—Rhinitis—Epirubicin—sarcoma	9.38e-05	0.000462	CcSEcCtD
Diclofenac—Abdominal pain—Etoposide—sarcoma	9.38e-05	0.000462	CcSEcCtD
Diclofenac—Body temperature increased—Etoposide—sarcoma	9.38e-05	0.000462	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—sarcoma	9.38e-05	0.000462	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—sarcoma	9.38e-05	0.000462	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—sarcoma	9.36e-05	0.000461	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—sarcoma	9.36e-05	0.000461	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—sarcoma	9.31e-05	0.000458	CcSEcCtD
Diclofenac—Vomiting—Vincristine—sarcoma	9.31e-05	0.000458	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—sarcoma	9.29e-05	0.000457	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—sarcoma	9.25e-05	0.000455	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—sarcoma	9.24e-05	0.000455	CcSEcCtD
Diclofenac—Rash—Vincristine—sarcoma	9.23e-05	0.000454	CcSEcCtD
Diclofenac—Dermatitis—Vincristine—sarcoma	9.22e-05	0.000454	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—sarcoma	9.22e-05	0.000454	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—sarcoma	9.2e-05	0.000453	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—sarcoma	9.17e-05	0.000452	CcSEcCtD
Diclofenac—Headache—Vincristine—sarcoma	9.17e-05	0.000452	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—sarcoma	9.12e-05	0.000449	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—sarcoma	9.1e-05	0.000448	CcSEcCtD
Diclofenac—ABCB1—liver—sarcoma	9.09e-05	0.00147	CbGeAlD
Diclofenac—Vomiting—Mitoxantrone—sarcoma	9.07e-05	0.000446	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—sarcoma	9.05e-05	0.000445	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—sarcoma	9.02e-05	0.000444	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—sarcoma	9e-05	0.000443	CcSEcCtD
Diclofenac—Rash—Mitoxantrone—sarcoma	8.99e-05	0.000443	CcSEcCtD
Diclofenac—Dermatitis—Mitoxantrone—sarcoma	8.98e-05	0.000442	CcSEcCtD
Diclofenac—Headache—Mitoxantrone—sarcoma	8.93e-05	0.00044	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—sarcoma	8.85e-05	0.000436	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—sarcoma	8.81e-05	0.000434	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—sarcoma	8.75e-05	0.000431	CcSEcCtD
Diclofenac—Hypersensitivity—Etoposide—sarcoma	8.74e-05	0.00043	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—sarcoma	8.73e-05	0.00043	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—sarcoma	8.7e-05	0.000428	CcSEcCtD
Diclofenac—Nausea—Vincristine—sarcoma	8.7e-05	0.000428	CcSEcCtD
Diclofenac—Flushing—Epirubicin—sarcoma	8.69e-05	0.000428	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—sarcoma	8.69e-05	0.000428	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—sarcoma	8.68e-05	0.000427	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—sarcoma	8.66e-05	0.000426	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—sarcoma	8.66e-05	0.000426	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—sarcoma	8.62e-05	0.000424	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—sarcoma	8.59e-05	0.000423	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—sarcoma	8.55e-05	0.000421	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—sarcoma	8.53e-05	0.00042	CcSEcCtD
Diclofenac—Asthenia—Etoposide—sarcoma	8.51e-05	0.000419	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—sarcoma	8.49e-05	0.000418	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—sarcoma	8.49e-05	0.000418	CcSEcCtD
Diclofenac—Nausea—Mitoxantrone—sarcoma	8.47e-05	0.000417	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—sarcoma	8.45e-05	0.000416	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—sarcoma	8.43e-05	0.000415	CcSEcCtD
Diclofenac—Chills—Epirubicin—sarcoma	8.4e-05	0.000413	CcSEcCtD
Diclofenac—Pruritus—Etoposide—sarcoma	8.39e-05	0.000413	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—sarcoma	8.36e-05	0.000412	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—sarcoma	8.34e-05	0.000411	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—sarcoma	8.27e-05	0.000407	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—sarcoma	8.2e-05	0.000404	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—sarcoma	8.19e-05	0.000403	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—sarcoma	8.15e-05	0.000401	CcSEcCtD
Diclofenac—Erythema—Epirubicin—sarcoma	8.15e-05	0.000401	CcSEcCtD
Diclofenac—Diarrhoea—Etoposide—sarcoma	8.12e-05	0.000399	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—sarcoma	8.09e-05	0.000398	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—sarcoma	8.07e-05	0.000397	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—sarcoma	8.04e-05	0.000396	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—sarcoma	8.04e-05	0.000396	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—sarcoma	8.03e-05	0.000395	CcSEcCtD
Diclofenac—Tension—Epirubicin—sarcoma	7.99e-05	0.000394	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—sarcoma	7.98e-05	0.000393	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—sarcoma	7.91e-05	0.000389	CcSEcCtD
Diclofenac—Back pain—Epirubicin—sarcoma	7.88e-05	0.000388	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—sarcoma	7.86e-05	0.000387	CcSEcCtD
Diclofenac—Dizziness—Etoposide—sarcoma	7.84e-05	0.000386	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—sarcoma	7.83e-05	0.000386	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—sarcoma	7.82e-05	0.000385	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—sarcoma	7.8e-05	0.000384	CcSEcCtD
Diclofenac—Chills—Doxorubicin—sarcoma	7.77e-05	0.000382	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—sarcoma	7.74e-05	0.000381	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—sarcoma	7.68e-05	0.000378	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—sarcoma	7.65e-05	0.000377	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—sarcoma	7.59e-05	0.000373	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—sarcoma	7.56e-05	0.000372	CcSEcCtD
Diclofenac—Vomiting—Etoposide—sarcoma	7.54e-05	0.000371	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—sarcoma	7.54e-05	0.000371	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—sarcoma	7.54e-05	0.000371	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—sarcoma	7.53e-05	0.000371	CcSEcCtD
Diclofenac—Agitation—Epirubicin—sarcoma	7.49e-05	0.000369	CcSEcCtD
Diclofenac—Rash—Etoposide—sarcoma	7.48e-05	0.000368	CcSEcCtD
Diclofenac—Dermatitis—Etoposide—sarcoma	7.47e-05	0.000368	CcSEcCtD
Diclofenac—Headache—Etoposide—sarcoma	7.43e-05	0.000366	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—sarcoma	7.43e-05	0.000366	CcSEcCtD
Diclofenac—Tension—Doxorubicin—sarcoma	7.4e-05	0.000364	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—sarcoma	7.38e-05	0.000363	CcSEcCtD
Diclofenac—Malaise—Epirubicin—sarcoma	7.35e-05	0.000362	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—sarcoma	7.32e-05	0.00036	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—sarcoma	7.32e-05	0.00036	CcSEcCtD
Diclofenac—Syncope—Epirubicin—sarcoma	7.31e-05	0.00036	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—sarcoma	7.29e-05	0.000359	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—sarcoma	7.29e-05	0.000359	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—sarcoma	7.25e-05	0.000357	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—sarcoma	7.2e-05	0.000354	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—sarcoma	7.16e-05	0.000352	CcSEcCtD
Diclofenac—Cough—Epirubicin—sarcoma	7.11e-05	0.00035	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—sarcoma	7.1e-05	0.00035	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—sarcoma	7.06e-05	0.000347	CcSEcCtD
Diclofenac—Nausea—Etoposide—sarcoma	7.05e-05	0.000347	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—sarcoma	7.03e-05	0.000346	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—sarcoma	6.99e-05	0.000344	CcSEcCtD
Diclofenac—ABCB1—lymph node—sarcoma	6.97e-05	0.00113	CbGeAlD
Diclofenac—Anaemia—Doxorubicin—sarcoma	6.97e-05	0.000343	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—sarcoma	6.94e-05	0.000341	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—sarcoma	6.94e-05	0.000341	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—sarcoma	6.94e-05	0.000341	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—sarcoma	6.93e-05	0.000341	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—sarcoma	6.91e-05	0.00034	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	6.89e-05	0.000339	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—sarcoma	6.85e-05	0.000337	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—sarcoma	6.8e-05	0.000335	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—sarcoma	6.78e-05	0.000334	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—sarcoma	6.77e-05	0.000333	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—sarcoma	6.76e-05	0.000333	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—sarcoma	6.75e-05	0.000332	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—sarcoma	6.7e-05	0.00033	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—sarcoma	6.66e-05	0.000328	CcSEcCtD
Diclofenac—Oedema—Epirubicin—sarcoma	6.65e-05	0.000327	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—sarcoma	6.65e-05	0.000327	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—sarcoma	6.62e-05	0.000326	CcSEcCtD
Diclofenac—Infection—Epirubicin—sarcoma	6.61e-05	0.000325	CcSEcCtD
Diclofenac—Cough—Doxorubicin—sarcoma	6.58e-05	0.000324	CcSEcCtD
Diclofenac—Shock—Epirubicin—sarcoma	6.54e-05	0.000322	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—sarcoma	6.53e-05	0.000321	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—sarcoma	6.52e-05	0.000321	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—sarcoma	6.51e-05	0.00032	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—sarcoma	6.51e-05	0.00032	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—sarcoma	6.49e-05	0.000319	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—sarcoma	6.46e-05	0.000318	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—sarcoma	6.43e-05	0.000316	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—sarcoma	6.42e-05	0.000316	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—sarcoma	6.42e-05	0.000316	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—sarcoma	6.42e-05	0.000316	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—sarcoma	6.4e-05	0.000315	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	6.37e-05	0.000314	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—sarcoma	6.34e-05	0.000312	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—sarcoma	6.34e-05	0.000312	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—sarcoma	6.28e-05	0.000309	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—sarcoma	6.21e-05	0.000306	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—sarcoma	6.2e-05	0.000305	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—sarcoma	6.15e-05	0.000303	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—sarcoma	6.15e-05	0.000303	CcSEcCtD
Diclofenac—Infection—Doxorubicin—sarcoma	6.11e-05	0.000301	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—sarcoma	6.06e-05	0.000298	CcSEcCtD
Diclofenac—Shock—Doxorubicin—sarcoma	6.05e-05	0.000298	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—sarcoma	6.03e-05	0.000297	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—sarcoma	6.02e-05	0.000297	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—sarcoma	6.01e-05	0.000296	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—sarcoma	6e-05	0.000296	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—sarcoma	5.98e-05	0.000294	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—sarcoma	5.97e-05	0.000294	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—sarcoma	5.95e-05	0.000293	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—sarcoma	5.93e-05	0.000292	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—sarcoma	5.91e-05	0.000291	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—sarcoma	5.86e-05	0.000289	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—sarcoma	5.85e-05	0.000288	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—sarcoma	5.78e-05	0.000285	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—sarcoma	5.75e-05	0.000283	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—sarcoma	5.74e-05	0.000283	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—sarcoma	5.73e-05	0.000282	CcSEcCtD
Diclofenac—Pain—Epirubicin—sarcoma	5.69e-05	0.00028	CcSEcCtD
Diclofenac—Constipation—Epirubicin—sarcoma	5.69e-05	0.00028	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—sarcoma	5.6e-05	0.000276	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—sarcoma	5.56e-05	0.000274	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—sarcoma	5.52e-05	0.000272	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—sarcoma	5.48e-05	0.00027	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—sarcoma	5.48e-05	0.00027	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—sarcoma	5.47e-05	0.000269	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—sarcoma	5.44e-05	0.000268	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—sarcoma	5.42e-05	0.000267	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—sarcoma	5.35e-05	0.000263	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—sarcoma	5.31e-05	0.000261	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—sarcoma	5.3e-05	0.000261	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—sarcoma	5.28e-05	0.00026	CcSEcCtD
Diclofenac—Pain—Doxorubicin—sarcoma	5.26e-05	0.000259	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—sarcoma	5.26e-05	0.000259	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—sarcoma	5.26e-05	0.000259	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—sarcoma	5.26e-05	0.000259	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—sarcoma	5.07e-05	0.00025	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—sarcoma	5.03e-05	0.000248	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—sarcoma	4.9e-05	0.000241	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—sarcoma	4.89e-05	0.000241	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—sarcoma	4.86e-05	0.000239	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—sarcoma	4.86e-05	0.000239	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—sarcoma	4.77e-05	0.000235	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—sarcoma	4.7e-05	0.000232	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—sarcoma	4.55e-05	0.000224	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—sarcoma	4.53e-05	0.000223	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—sarcoma	4.41e-05	0.000217	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—sarcoma	4.4e-05	0.000216	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—sarcoma	4.35e-05	0.000214	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—sarcoma	4.23e-05	0.000208	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—sarcoma	4.21e-05	0.000207	CcSEcCtD
Diclofenac—Rash—Epirubicin—sarcoma	4.19e-05	0.000206	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—sarcoma	4.19e-05	0.000206	CcSEcCtD
Diclofenac—Headache—Epirubicin—sarcoma	4.17e-05	0.000205	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—sarcoma	4.07e-05	0.0002	CcSEcCtD
Diclofenac—Nausea—Epirubicin—sarcoma	3.95e-05	0.000194	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—sarcoma	3.91e-05	0.000193	CcSEcCtD
Diclofenac—Rash—Doxorubicin—sarcoma	3.88e-05	0.000191	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—sarcoma	3.88e-05	0.000191	CcSEcCtD
Diclofenac—Headache—Doxorubicin—sarcoma	3.85e-05	0.00019	CcSEcCtD
Diclofenac—SCN4A—Developmental Biology—CTNNB1—sarcoma	3.7e-05	0.000641	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PLCG1—sarcoma	3.68e-05	0.000637	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—FLT1—sarcoma	3.67e-05	0.000635	CbGpPWpGaD
Diclofenac—Nausea—Doxorubicin—sarcoma	3.65e-05	0.00018	CcSEcCtD
Diclofenac—KCNQ2—Developmental Biology—KRAS—sarcoma	3.65e-05	0.000633	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—KRAS—sarcoma	3.65e-05	0.000633	CbGpPWpGaD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.65e-05	0.000633	CbGpPWpGaD
Diclofenac—TTR—Disease—FOXO1—sarcoma	3.65e-05	0.000633	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TLE1—sarcoma	3.65e-05	0.000632	CbGpPWpGaD
Diclofenac—TTR—Disease—PDGFRB—sarcoma	3.64e-05	0.000631	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	3.61e-05	0.000626	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PLCG1—sarcoma	3.6e-05	0.000624	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	3.6e-05	0.000623	CbGpPWpGaD
Diclofenac—TTR—Disease—PDGFRA—sarcoma	3.59e-05	0.000622	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	3.58e-05	0.00062	CbGpPWpGaD
Diclofenac—ALB—Platelet degranulation—VEGFA—sarcoma	3.57e-05	0.000619	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	3.5e-05	0.000607	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	3.5e-05	0.000607	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	3.5e-05	0.000607	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	3.5e-05	0.000607	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CXCR4—sarcoma	3.46e-05	0.0006	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—IL2—sarcoma	3.45e-05	0.000598	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ATF1—sarcoma	3.42e-05	0.000593	CbGpPWpGaD
Diclofenac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	3.4e-05	0.00059	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TLE1—sarcoma	3.4e-05	0.000589	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.37e-05	0.000583	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—SRC—sarcoma	3.34e-05	0.000579	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.31e-05	0.000573	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—HRAS—sarcoma	3.3e-05	0.000571	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—VEGFA—sarcoma	3.26e-05	0.000564	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—NRAS—sarcoma	3.22e-05	0.000557	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFC—sarcoma	3.22e-05	0.000557	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.16e-05	0.000548	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—sarcoma	3.15e-05	0.000546	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—KDR—sarcoma	3.14e-05	0.000545	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—HRAS—sarcoma	3.11e-05	0.000538	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—HRAS—sarcoma	3.11e-05	0.000538	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFC—sarcoma	3.08e-05	0.000533	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	3.07e-05	0.000532	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NPM1—sarcoma	3.06e-05	0.000531	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—MYC—sarcoma	2.98e-05	0.000516	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EGFR—sarcoma	2.93e-05	0.000508	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—sarcoma	2.93e-05	0.000508	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ENO2—sarcoma	2.92e-05	0.000505	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—EGFR—sarcoma	2.91e-05	0.000505	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.9e-05	0.000502	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—HBA1—sarcoma	2.9e-05	0.000502	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—KIT—sarcoma	2.9e-05	0.000502	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—NRAS—sarcoma	2.9e-05	0.000502	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ENO2—sarcoma	2.84e-05	0.000492	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—HBA1—sarcoma	2.82e-05	0.000489	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.81e-05	0.000487	CbGpPWpGaD
Diclofenac—TTR—Disease—KIT—sarcoma	2.78e-05	0.000482	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—KRAS—sarcoma	2.77e-05	0.00048	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CREB1—sarcoma	2.76e-05	0.000477	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—MMP2—sarcoma	2.69e-05	0.000465	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IGF1R—sarcoma	2.69e-05	0.000465	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ENO2—sarcoma	2.65e-05	0.00046	CbGpPWpGaD
Diclofenac—TTR—Disease—CREB1—sarcoma	2.65e-05	0.000459	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—EGFR—sarcoma	2.64e-05	0.000457	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—FOXO1—sarcoma	2.56e-05	0.000443	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PDGFRB—sarcoma	2.55e-05	0.000442	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PLCG1—sarcoma	2.53e-05	0.000438	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.53e-05	0.000437	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.52e-05	0.000437	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PDGFRA—sarcoma	2.51e-05	0.000435	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.5e-05	0.000433	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—KRAS—sarcoma	2.49e-05	0.000432	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.48e-05	0.00043	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PLCG1—sarcoma	2.48e-05	0.000429	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—FLT1—sarcoma	2.46e-05	0.000426	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—sarcoma	2.45e-05	0.000424	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PLCG1—sarcoma	2.42e-05	0.000419	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PLCG1—sarcoma	2.41e-05	0.000417	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—HRAS—sarcoma	2.35e-05	0.000408	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CXCR4—sarcoma	2.32e-05	0.000402	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ENO2—sarcoma	2.31e-05	0.000399	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ATF1—sarcoma	2.3e-05	0.000398	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—HBA1—sarcoma	2.29e-05	0.000397	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TLE1—sarcoma	2.28e-05	0.000395	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MDM2—sarcoma	2.28e-05	0.000395	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.26e-05	0.000392	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PLCG1—sarcoma	2.25e-05	0.00039	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ENO2—sarcoma	2.22e-05	0.000385	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—HBA1—sarcoma	2.21e-05	0.000383	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.2e-05	0.000381	CbGpPWpGaD
Diclofenac—TTR—Disease—MDM2—sarcoma	2.19e-05	0.00038	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CXCR4—sarcoma	2.16e-05	0.000375	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—IL2—sarcoma	2.12e-05	0.000368	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HRAS—sarcoma	2.12e-05	0.000367	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KDR—sarcoma	2.11e-05	0.000366	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—CREB1—sarcoma	2.11e-05	0.000365	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—CTNNB1—sarcoma	2.06e-05	0.000357	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NPM1—sarcoma	2.06e-05	0.000356	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.06e-05	0.000356	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL2—sarcoma	2.04e-05	0.000353	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.03e-05	0.000351	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CCND1—sarcoma	1.99e-05	0.000344	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—JUN—sarcoma	1.98e-05	0.000343	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.98e-05	0.000343	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CTNNB1—sarcoma	1.97e-05	0.000341	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PLCG1—sarcoma	1.96e-05	0.000339	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KIT—sarcoma	1.95e-05	0.000338	CbGpPWpGaD
Diclofenac—TTR—Disease—CTNNB1—sarcoma	1.89e-05	0.000327	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PLCG1—sarcoma	1.89e-05	0.000327	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ENO2—sarcoma	1.88e-05	0.000326	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.87e-05	0.000324	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—HBA1—sarcoma	1.87e-05	0.000324	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	1.86e-05	0.000323	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CREB1—sarcoma	1.85e-05	0.000321	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—SRC—sarcoma	1.85e-05	0.000321	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—VEGFA—sarcoma	1.81e-05	0.000313	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IGF1R—sarcoma	1.8e-05	0.000312	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.79e-05	0.00031	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.79e-05	0.000309	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NRAS—sarcoma	1.78e-05	0.000309	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ENO2—sarcoma	1.78e-05	0.000309	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—SRC—sarcoma	1.78e-05	0.000308	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.77e-05	0.000307	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—VEGFA—sarcoma	1.73e-05	0.0003	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—FOXO1—sarcoma	1.71e-05	0.000297	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—IL2—sarcoma	1.71e-05	0.000297	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PDGFRB—sarcoma	1.71e-05	0.000297	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NRAS—sarcoma	1.71e-05	0.000296	CbGpPWpGaD
Diclofenac—TTR—Disease—SRC—sarcoma	1.71e-05	0.000296	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PDGFRA—sarcoma	1.69e-05	0.000292	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.66e-05	0.000288	CbGpPWpGaD
Diclofenac—TTR—Disease—NRAS—sarcoma	1.64e-05	0.000285	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	1.63e-05	0.000282	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.6e-05	0.000278	CbGpPWpGaD
Diclofenac—ABCC1—Disease—FOXO1—sarcoma	1.6e-05	0.000277	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PDGFRB—sarcoma	1.6e-05	0.000276	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PLCG1—sarcoma	1.59e-05	0.000276	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MYC—sarcoma	1.59e-05	0.000276	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.58e-05	0.000275	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PDGFRA—sarcoma	1.57e-05	0.000272	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.56e-05	0.00027	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EGFR—sarcoma	1.56e-05	0.00027	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL2—sarcoma	1.56e-05	0.00027	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—KRAS—sarcoma	1.53e-05	0.000266	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MDM2—sarcoma	1.53e-05	0.000266	CbGpPWpGaD
Diclofenac—TTR—Disease—MYC—sarcoma	1.53e-05	0.000265	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PLCG1—sarcoma	1.51e-05	0.000262	CbGpPWpGaD
Diclofenac—TTR—Disease—EGFR—sarcoma	1.5e-05	0.000259	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ENO2—sarcoma	1.49e-05	0.000259	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—HBA1—sarcoma	1.48e-05	0.000257	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—KRAS—sarcoma	1.47e-05	0.000255	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CXCR4—sarcoma	1.45e-05	0.000252	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.44e-05	0.000249	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ENO2—sarcoma	1.43e-05	0.000248	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—HBA1—sarcoma	1.43e-05	0.000247	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KDR—sarcoma	1.42e-05	0.000246	CbGpPWpGaD
Diclofenac—TTR—Disease—KRAS—sarcoma	1.41e-05	0.000245	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ENO2—sarcoma	1.4e-05	0.000243	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.4e-05	0.000243	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—HBA1—sarcoma	1.4e-05	0.000242	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL2—sarcoma	1.37e-05	0.000238	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—sarcoma	1.36e-05	0.000236	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CCND1—sarcoma	1.34e-05	0.000232	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—JUN—sarcoma	1.33e-05	0.000231	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.33e-05	0.00023	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ENO2—sarcoma	1.32e-05	0.000229	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CTNNB1—sarcoma	1.32e-05	0.000229	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—HBA1—sarcoma	1.32e-05	0.000228	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—sarcoma	1.31e-05	0.000227	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KIT—sarcoma	1.31e-05	0.000226	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NRAS—sarcoma	1.31e-05	0.000226	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—sarcoma	1.3e-05	0.000226	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PLCG1—sarcoma	1.27e-05	0.000219	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—sarcoma	1.25e-05	0.000217	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CREB1—sarcoma	1.24e-05	0.000215	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KIT—sarcoma	1.22e-05	0.000211	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PLCG1—sarcoma	1.22e-05	0.000211	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ENO2—sarcoma	1.21e-05	0.00021	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ENO2—sarcoma	1.21e-05	0.000209	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—HBA1—sarcoma	1.21e-05	0.000209	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—sarcoma	1.2e-05	0.000208	CbGpPWpGaD
Diclofenac—ALB—Metabolism—HBA1—sarcoma	1.2e-05	0.000208	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SRC—sarcoma	1.2e-05	0.000207	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PLCG1—sarcoma	1.19e-05	0.000206	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—sarcoma	1.19e-05	0.000206	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.18e-05	0.000204	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—sarcoma	1.17e-05	0.000202	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CREB1—sarcoma	1.16e-05	0.000201	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NRAS—sarcoma	1.15e-05	0.000199	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—KRAS—sarcoma	1.12e-05	0.000195	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PLCG1—sarcoma	1.12e-05	0.000195	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ENO2—sarcoma	1.08e-05	0.000188	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—HBA1—sarcoma	1.08e-05	0.000187	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FOXO1—sarcoma	1.07e-05	0.000186	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MYC—sarcoma	1.07e-05	0.000186	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PDGFRB—sarcoma	1.07e-05	0.000186	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ENO2—sarcoma	1.06e-05	0.000183	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PDGFRA—sarcoma	1.05e-05	0.000183	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—HBA1—sarcoma	1.05e-05	0.000182	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—sarcoma	1.05e-05	0.000182	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PLCG1—sarcoma	1.03e-05	0.000178	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MDM2—sarcoma	1.03e-05	0.000178	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PLCG1—sarcoma	1.02e-05	0.000177	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KRAS—sarcoma	9.91e-06	0.000172	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ENO2—sarcoma	9.88e-06	0.000171	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HBA1—sarcoma	9.82e-06	0.00017	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IL2—sarcoma	9.61e-06	0.000167	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MDM2—sarcoma	9.59e-06	0.000166	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—sarcoma	9.56e-06	0.000166	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PLCG1—sarcoma	9.2e-06	0.000159	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL2—sarcoma	9.2e-06	0.000159	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PLCG1—sarcoma	8.98e-06	0.000155	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—sarcoma	8.96e-06	0.000155	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—JUN—sarcoma	8.94e-06	0.000155	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CTNNB1—sarcoma	8.88e-06	0.000154	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—sarcoma	8.8e-06	0.000153	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ENO2—sarcoma	8.44e-06	0.000146	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—sarcoma	8.42e-06	0.000146	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HBA1—sarcoma	8.39e-06	0.000145	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SRC—sarcoma	8.39e-06	0.000145	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PLCG1—sarcoma	8.38e-06	0.000145	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—sarcoma	8.27e-06	0.000143	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KIT—sarcoma	8.17e-06	0.000142	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—sarcoma	8.17e-06	0.000142	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—sarcoma	8.07e-06	0.00014	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SRC—sarcoma	8.02e-06	0.000139	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—sarcoma	7.81e-06	0.000135	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CREB1—sarcoma	7.78e-06	0.000135	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—sarcoma	7.72e-06	0.000134	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SRC—sarcoma	7.48e-06	0.00013	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—sarcoma	7.19e-06	0.000125	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—sarcoma	7.19e-06	0.000125	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PLCG1—sarcoma	7.17e-06	0.000124	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—sarcoma	7.03e-06	0.000122	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—sarcoma	6.95e-06	0.00012	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—sarcoma	6.7e-06	0.000116	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—sarcoma	6.64e-06	0.000115	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—sarcoma	6.56e-06	0.000114	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO2—sarcoma	6.52e-06	0.000113	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HBA1—sarcoma	6.48e-06	0.000112	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—sarcoma	6.44e-06	0.000112	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—sarcoma	6.19e-06	0.000107	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—sarcoma	6.17e-06	0.000107	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—sarcoma	5.9e-06	0.000102	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—sarcoma	5.9e-06	0.000102	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—sarcoma	5.65e-06	9.78e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—sarcoma	5.55e-06	9.62e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLCG1—sarcoma	5.53e-06	9.58e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—sarcoma	5.26e-06	9.12e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—sarcoma	5.02e-06	8.7e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—sarcoma	4.83e-06	8.37e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—sarcoma	4.5e-06	7.79e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—sarcoma	4.4e-06	7.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—sarcoma	4.16e-06	7.2e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—sarcoma	3.53e-06	6.12e-05	CbGpPWpGaD
